Stockreport

Lantern Pharma and Oregon partner to develop cancer treatment [Yahoo! Finance]

Lantern Pharma Inc.  (LTRN) 
PDF XCE853 is an inhibitor of protein disulfide isomerase (PDI). The partnership will utilise RADR AI platform of Lantern to identify biomarkers and efficacy-linked signa [Read more]